Early screening for prostate cancer in men aged 40 to 65 in Syria
Tests a PSA blood test and a rectal exam to detect prostate cancer early.
Plain-language title generated from the registry record
Registry title: Early Detection of Prostate Cancer of Syrian Men
Key facts
- Where
- Homs, SyriaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for men living in the middle region of Syria who have not been diagnosed with prostate cancer, to test early detection.
- Age
- 40 to 65 years. The inclusion criteria say 40 years and older, while the age fields list 40 Years as the minimum and 65 Years as the maximum.
- Sex
- Men only.
Main reasons for not taking part
- Men with a previous diagnosis of prostate cancer cannot join.
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 65 years old?
Source: NCT07075666, who can take part
Where in Syria
- Al-Hawash Private UniversityHoms, SyriaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Al-Hawash Private University
- Trial code
- NCT07075666
- Record updated
- 20 July 2025
- Original description
Prostate cancer is a significant health concern in the Middle East, including Syria, where many cases are diagnosed at advanced stages due to low awareness and inadequate screening practices. The mortality-to-incidence ratio for prostate cancer in the region is alarmingly high, indicating a pressing need for effective early detection strategies.Read full original descriptionShow less
Early Detection of Prostate Cancer Among Men in the Middle Region of Syria
Prostate cancer is a significant health concern in the Middle East, including Syria, where many cases are diagnosed at advanced stages due to low awareness and inadequate screening practices. The mortality-to-incidence ratio for prostate cancer in the region is alarmingly high, indicating a pressing need for effective early detection strategies.
Inclusion: Men aged 40 years and older residing in the middle region of Syria.
Exclusion: Men with a previous diagnosis of prostate cancer.